BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28057714)

  • 21. Elevated expression of BAFF receptor, BR3, on monocytes correlates with B cell activation and clinical features of patients with primary Sjögren's syndrome.
    Yoshimoto K; Suzuki K; Takei E; Ikeda Y; Takeuchi T
    Arthritis Res Ther; 2020 Jun; 22(1):157. PubMed ID: 32576236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.
    Nishikawa A; Suzuki K; Kassai Y; Gotou Y; Takiguchi M; Miyazaki T; Yoshimoto K; Yasuoka H; Yamaoka K; Morita R; Yoshimura A; Takeuchi T
    Arthritis Res Ther; 2016 May; 18(1):106. PubMed ID: 27180164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum amyloid A and C-reactive protein concentrations are differently associated with markers of autoimmunity in patients with primary Sjögren's syndrome.
    Pertovaara M; Jylhävä J; Uusitalo H; Pukander J; Helin H; Hurme M
    J Rheumatol; 2009 Nov; 36(11):2487-90. PubMed ID: 19833744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocyte-specific S100A8/A9 is upregulated in primary Sjögren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Nicaise C; Weichselbaum L; Schandene L; Gangji V; Dehavay F; Bouchat J; Balau B; Vogl T; Soyfoo MS
    Clin Exp Rheumatol; 2017; 35(1):129-136. PubMed ID: 27749214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
    Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
    Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome.
    Liu Y; Liao X; Wang Y; Chen S; Sun Y; Lin Q; Shi G
    Oncotarget; 2017 Feb; 8(9):14306-14313. PubMed ID: 28147328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome.
    Liu TT; Zeng XP; Gu ML; Deng AM
    Int J Rheum Dis; 2020 May; 23(5):654-660. PubMed ID: 32180363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum IgA against type 3 muscarinic acetylcholine receptor is a novel marker in diagnosis of Sjögren's syndrome.
    Li YN; Guo JP; He J; Liu X; Yin FR; Ding Y; Yao HH; Kang AJ; Li ZG
    Chin Med J (Engl); 2011 Aug; 124(16):2490-5. PubMed ID: 21933593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life in patients with primary Sjögren's syndrome: relationship with serum levels of proinflammatory cytokines.
    Baturone R; Soto MJ; Márquez M; Macías I; de Oca MM; Medina F; Chozas N; García-Pérez S; Girón-González JA
    Scand J Rheumatol; 2009; 38(5):386-9. PubMed ID: 19575332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of long-term medication of oral steroids and antimalarial drugs in primary Sjögren's syndrome.
    Reksten TR; Brokstad KA; Jonsson R; Brun JG; Jonsson MV
    Int Immunopharmacol; 2011 Dec; 11(12):2125-9. PubMed ID: 21964047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni E; Carubbi F; Gregoraci G; Gandolfo S; Salvin S; Luciano N; Minniti A; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    Scand J Rheumatol; 2015; 44(1):36-41. PubMed ID: 25268749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low copy number of the Fc-γ receptor 3B gene FCGR3B is a risk factor for primary Sjogren's syndrome.
    Nossent JC; Rischmueller M; Lester S
    J Rheumatol; 2012 Nov; 39(11):2142-7. PubMed ID: 22942264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome.
    Willeke P; Schotte H; Schlüter B; Erren M; Becker H; Dyong A; Mickholz E; Domschke W; Gaubitz M
    Ann Rheum Dis; 2003 Apr; 62(4):359-62. PubMed ID: 12634239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased serum levels of high-mobility group box 1 (HMGB1) in primary Sjögren's syndrome.
    Dupire G; Nicaise C; Gangji V; Soyfoo MS
    Scand J Rheumatol; 2012 Mar; 41(2):120-3. PubMed ID: 22248244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren's syndrome.
    Olsson P; Skogstrand K; Nilsson A; Turesson C; Jacobsson LTH; Theander E; Houen G; Mandl T
    Rheumatol Int; 2018 Aug; 38(8):1503-1510. PubMed ID: 29846789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding protein.
    Novick D; Elbirt D; Miller G; Dinarello CA; Rubinstein M; Sthoeger ZM
    J Autoimmun; 2010 Mar; 34(2):121-6. PubMed ID: 19699611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex steroid hormones in primary Sjögren's syndrome.
    Brennan MT; Sankar V; Leakan RA; Grisius MM; Collins MT; Fox PC; Baum BJ; Pillemer SR
    J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.
    Lopes AP; Hillen MR; Chouri E; Blokland SLM; Bekker CPJ; Kruize AA; Rossato M; van Roon JAG; Radstake TRDJ
    PLoS One; 2018; 13(2):e0193157. PubMed ID: 29447268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum immunoglobulin G4 in Sjögren's syndrome: a pilot study.
    Maślińska M; Wojciechowska B; Mańczak M; Kwiatkowska B
    Rheumatol Int; 2020 Apr; 40(4):555-561. PubMed ID: 32062697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.